The benefit of exercise rehabilitation guided by 6-minute walk test on lipoprotein-associated phospholipase A2 in patients with coronary heart disease undergoing percutaneous coronary intervention: a prospective randomized controlled study

Table 3 The single factor linear regression analysis of the Lp-PLA2 level in group B after 12 weeks

Independent variable	Constant	β	SE	β′	t	P
Exercise rehabilitation	282.383	− 63.258	22.164	− 0.287	− 2.854	0.005
Age (years)	149.008	0.637	1.426	0.047	0.447	0.656
Male (%)	114.712	58.665	25.696	0.233	2.283	0.025
Hypertention (%)	178.358	8.006	9.118	0.092	0.878	0.382
T2DM (%)	190.118	− 8.765	29.899	− 0.031	− 0.293	0.77
BMI (kg/m²)	168.392	0.837	3.324	0.026	0.245	0.807
TC (mmol/l)	125.194	16.012	13.559	0.124	1.181	0.241
TG (mmol/l)	152.203	23.698	12.832	0.192	1.847	0.068
Lp (a) (mmol/l)	176.695	0.34	0.345	0.104	0.984	0.328
ApoA (g/l)	237.693	− 36.466	41.367	− 0.093	− 0.882	0.38
ApoB (g/l)	148.409	54.909	57.794	0.1	0.95	0.345
HDL-C (mmol/l)	215.76	− 23.485	38.042	− 0.065	− 0.617	0.539
LDL-C (mmol/l)	115.75	32.983	17.461	0.197	1.889	0.062

Lp-PLA2 Lipoprotein-associated Phospholipase A2, T2DM type-2 diabetes mellitus, BMI body mass index, TC total cholesterol, TG three acyl glycerin, ApoA apolipoprotein A, ApoB apolipoprotein B, Lp (a) lipoprotein (a), LDL-C low density lipoprotein cholesterol, HDL-C high density lipoprotein cholesterol

ISSN: 1471-2261